Opium Consumption and Myocardial Infarction in Osteoarthritis Patients: A Propensity Score Matched Cohort Study

Document Type : Original Article

Authors

1 Department of Statistics and Epidemiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

2 Department of Pharmacology, Faculty of Medical, Fasa University of Medical Sciences, Fasa, Iran

3 Department of Statistics and Epidemiology, Faculty of Medical, Fasa University of Medical Sciences, Fasa, Iran

4 Health Metrics and Evaluation Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Kurdistan, Iran

10.34172/ahj.1676

Abstract

Introduction: In recent years, the use of drugs with opioid compounds in patients with osteoarthritis has attracted increasing attention. However, long-term use of these drugs may cause severe side effects, including cardiovascular diseases. The present study aimed to investigate the relationship between the use of opium substances and myocardial infarction in osteoarthritis patients using a propensity score matching (PSM) approach.
Methods: We designed this study as a retrospective cohort study. The data were collected from 2016 to 2020. We identified confounding variables using the modified disjunctive cause criterion method. We matched individuals exposed to opium (opium users) and those unexposed to opium (non-users) by propensity score. We examined the distributions of opium users and non-users, both with and without propensity score matching. To determine the relationship between exposure to opium and heart attack in osteoarthritis patients, the Cox regression method was used.
Founding: The participants’ mean age was 49.85 ± 9.61 years, with 32.3% being men and 67.7% being women. We excluded individuals with cardiovascular disease from the baseline examination. Before PSM, the incidence rate in the total study sample was 2.96 per 1000 person-years. The relationship between opium consumption and heart attack was inverse before matching (hazard ratio, HR 0.73, 95% confidence interval (95% CI 0.58-0.98). After matching, the HR showed an increase of 24% (HR 1.24, 95% CI 0.87-1.76)
Conclusion: The findings of the present study suggest that opioid consumption is associated with an increased risk of heart attacks in osteoarthritis patients. Confirmation of this finding in future studies would indicate the need for monitoring these patients with a view towards primary prevention of modifiable cardiovascular risk factors.

Highlights

Daem Roshani(GoogleScholar)(Pubmed)

Keywords

References

  1. Allen KD, Golightly YM. State of the evidence. Curr Opin Rheumatol 2015;27(3):276-83. doi:10.1097/ bor.0000000000000161
  2. van Laar M, Pergolizzi JV Jr, Mellinghoff HU, Merchante IM, Nalamachu S, O’Brien J, et al. Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J 2012;6:320- 30. doi:10.2174/1874312901206010320
  3. Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol 2022;74(7):1172-83. doi:10.1002/ art.42089
  4. Network GBoDC. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle: Institute for Health Metrics and Evaluation (IHME); 2020. Available from: https://vizhub. healthdata.org/gbd-results/. Accessed April 15, 2025.
  5. Cacchione PZ. World Health Organization leads the 2021 to 2030-decade of healthy ageing. Clin Nurs Res 2022;31(1):3-4. doi:10.1177/10547738211065790
  6. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet 2020;396(10264):1711- 2. doi:10.1016/s0140-6736(20)32230-3
  7. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 2020;72(2):220- 33. doi:10.1002/art.41142
  8. Vonkeman HE, Fernandes RW, van de Laar MA. Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers. Int J Clin Pharmacol Ther 2007;45(5):281-8. doi:10.5414/cpp45281
  9. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(12):1634-42. doi:10.1161/circulationaha.106.181424
  10. Grässel S, Muschter D. Recent advances in the treatment of osteoarthritis. F1000Res 2020;9:F1000 Faculty Rev-325. doi:10.12688/f1000research.22115.1
  11. Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, et al. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ 2017;357:j1909. doi:10.1136/bmj.j1909
  12. Cheetham TC, Graham DJ, Campen D, Hui R, Spence M, Levy G, et al. Myocardial infarction and its association with the use of nonselective NSAIDs: a nested case-control and time-to-event analysis. Perm J 2008;12(1):16-22. doi:10.7812/tpp/07- 081
  13. Masclee GM, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, et al. Risk of acute myocardial infarction during use of individual NSAIDs: a nested case-control study from the SOS project. PLoS One 2018;13(11):e0204746. doi:10.1371/ journal.pone.0204746
  14. Thöne K, Kollhorst B, Schink T. Non-steroidal anti-inflammatory drug use and the risk of acute myocardial infarction in the general German population: a nested case-control study. Drugs Real World Outcomes 2017;4(3):127-37. doi:10.1007/ s40801-017-0113-x
  15. Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001- 2010. Pharmacoepidemiol Drug Saf 2015;24(8):885-92. doi:10.1002/pds.3776
  16. Birke H, Kurita GP, Sjøgren P, Højsted J, Simonsen MK, Juel K, et al. Chronic non-cancer pain and the epidemic prescription of opioids in the Danish population: trends from 2000 to 2013. Acta Anaesthesiol Scand 2016;60(5):623-33. doi:10.1111/ aas.12700
  17. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16(5):405-16. doi:10.1037/a0013628
  18. Abdollahi MH, Forouzannia SK, Zare S. Demografic characteristics of opioid addiction in patients undergoing coronary artery bypass graft. Tehran Univ Med J 2006;64(10):54-9.
  19. Aghadavoudi O, Eizadi-Mood N, Najarzadegan MR. Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery. Adv Biomed Res 2015;4:12. doi:10.4103/2277-9175.148294
  20. Esmaeili Nadimi A, Pour Amiri F, Sheikh Fathollahi M, Hassanshahi G, Ahmadi Z, Sayadi AR. Opium addiction as an independent risk factor for coronary microvascular dysfunction: a case-control study of 250 consecutive patients with slow-flow angina. Int J Cardiol 2016;219:301-7. doi:10.1016/j.ijcard.2016.06.034
  21. Rahimi Darabad B, Vatandust J, Pourmousavi Khoshknab MM, Hajahmadi Poorrafsanjani M. Survey of the effect of opioid abuse on the extent of coronary artery diseases. Glob J Health Sci 2014;6(7 Spec No):83-91. doi:10.5539/gjhs.v6n7p83
  22. Rezvani MR, Ghandehari K. Is opium addiction a risk factor for ischemic heart disease and ischemic stroke? J Res Med Sci 2012;17(10):958-61.
  23. Harati H, Shamsi A, Firouzkouhi Moghadam M, Seyed Zadeh FS, Ghazi A. The mortality rate of myocardial infraction patients with and without opium dependen. Int J High Risk Behav Addict 2015;4(3):e22576. doi:10.5812/ijhrba.22576
  24. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46(3):399-424. doi:10.1080/002 73171.2011.568786
  25. Postchi H, Eghtesad S, Mohammadi M, Rozafzay F, Mahmoodi Z, Shayanrad A. Prospective Epidemiological Research Studies in Iran, PERSIAN Cohort, Study Protocol. 1st ed. Tehran: Mir Mah Publication; 2016.
  26. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol 2018;187(4):647-55. doi:10.1093/aje/kwx314
  27. Negroiu CE, Tudorascu I, Moise CG, Vinturis E, Bezna CM, Danoiu R, et al. Obesity and myocardial infarction-the place of obesity among cardiovascular risk factors-retrospective study. Curr Health Sci J 2023;49(3):388-96. doi:10.12865/ chsj.49.03.11
  28. Jiang SZ, Lu W, Zong XF, Ruan HY, Liu Y. Obesity and hypertension. Exp Ther Med 2016;12(4):2395-9. doi:10.3892/ etm.2016.3667
  29. Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas 2016;89:22-8. doi:10.1016/j. maturitas.2016.04.006
  30. Golabi S, Varmaghani A, Mohammadi SM, Karimiyarandi H, Naghashpour M. Malnutrition diagnosis in outpatients with knee osteoarthritis: a hospital-based case-control study in Iranian population. Nutr Food Health Dis 2025;12(2):35-45. doi:10.61186/nfsr.12.2.35
  31. World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992. p. 362.
  32. Baek S, Park SH, Won E, Park YR, Kim HJ. Propensity score matching: a conceptual review for radiology researchers. Korean J Radiol 2015;16(2):286-96. doi:10.3348/ kjr.2015.16.2.286
  33. Govindasamy P. A Comparison Between Propensity Score Matching, Weighting, and Stratification in Multiple Treatment Groups: A Simulation Study [dissertation]. University of Denver; 2016.
  34. Lunt M. Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching. Am J Epidemiol 2014;179(2):226-35. doi:10.1093/aje/kwt212
  35. Park D, Park YM, Ko SH, Choi YH, Min DU, Ahn JH, et al. Association between knee osteoarthritis and the risk of cardiovascular disease and the synergistic adverse effects of lack of exercise. Sci Rep 2023;13(1):2777. doi:10.1038/ s41598-023-29581-1
  36. Korsgaard S, Munch T, Horváth-Puhó E, Adelborg K, Christiansen CF, Pedersen L, et al. Preadmission opioid use and 1-year mortality following incident myocardial infarction: a Danish population-based cohort study (1997- 2016). J Am Heart Assoc 2023;12(6):e026251. doi:10.1161/ jaha.122.026251
  37. Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, et al. The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007;14(5):715- 7. doi:10.1097/HJR.0b013e328045c4e9
  38. Masoomi M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Int J Prev Med 2010;1(3):182-6.
  39. Pontes C, Marsal JR, Elorza JM, Aragón M, Prieto-Alhambra D, Morros R. Analgesic use and risk for acute coronary events in patients with osteoarthritis: a population-based, nested case-control study. Clin Ther 2018;40(2):270-83. doi:10.1016/j. clinthera.2017.12.011
  40. Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of myocardial infarction amongst adults. J Intern Med 2013;273(5):511-26. doi:10.1111/joim.12035
  41. Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 2017;76(8):1396-404. doi:10.1136/annrheumdis-2016-210275
  42. Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A. Comparison of specifications, short term outcome and prognosis of acute myocardial infarction in opium dependent patients and non-dependents. Res Heart Yield Transl Med 2006;1(1):48-53.
  43. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. Jones & Bartlett Publishers; 2001.
Addiction & Health
Volume 18
Pages 1-7

Files

Share

How to cite

Statistics